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“New” and “Emerging Science” and “Technologies” (“NESTs”) have tremendous innovation
potential. However this must be weighed against enormous uncertainties caused by many
unknowns. The authors of this paper offer a framework to analyze NESTs to help ascertain likely
innovation pathways. We have devised a 10-step framework based on extensive Future-oriented
Technology Analyses (“FTA”) experience, enriched by in-depth case analyses. In the paper, we
describe our analytical activities in two case studies. The nanobiosensor experience is contrasted
with that of deepbrain stimulation in relative quantitative and qualitative emphases.We close the
paper by reflecting on this systematic FTA framework for emerging science and technologies, for
its intended goal, that is to support decision making.
© 2011 Elsevier Inc. All rights reserved.
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1. Introduction
In an age of strategic science and high-investment projects decision makers want to identify possible and promising directions
and options for technology emergence in advance, to help choose the right path. New and emerging science and technologies,
such as proteomics, bioelectronics or nanotechnologies, may impact many sectors with a variety of industrial structures.
Regulation and policy instruments therefore need support systems to augment their targets — a variety of (and often shifting)
industrial contexts. This emphasizes the requirement of relevant and timely strategic intelligence to enable effective decision
making and strategy development.
For sucha support system, FTA tools have to bewell tailored to be able to capture the complexworld of emerging technologyﬁelds,
at an early stage, and be robust enough to produceuseful intelligence in real-time, oftenwhen data are heterogeneous and dispersed.4
Research and innovation activities for NESTs are embedded in uncertainties, promises, and, sometimes, concerns because:
• The technology is either new or rapidly evolving;
• Applications and markets range from the non-existent to relatively advanced;
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• Knowledge is emerging in distributed pockets of research and development, often with no easily identiﬁable community;
• A variety of objectives and visions proliferate; and
• The platform nature of many new technologies means that a variety of routes to diverse applications may be possible.
Thus, FTA for NESTs requires adaptation of traditional technology forecasting methods. Furthermore, the variations within
NEST technology management situations demand that FTAmethodologies be ﬂexible. For instance, in one case one may have time
series data on technical parameters and market development; in other cases, this may not be so.
“Nano” (nanoscience and nanotechnology) includes a range of potential NESTs. In contrast with biotechnology or neuro-cognitive
science, nano is not a domain with substantial coherence. It can be deﬁned as being about everything interesting that happens at the
molecular level. Nano is an umbrella term (continuing to exist because of the rhetorical and resource-mobilization force of the label),
and under this umbrella there are domains with very different dynamics.
Unlike previous high-technology waves, nanotechnology covers diverse ﬁelds of sciences and engineering, crosses boundaries
between them, and aims to utilize the very fundamental characteristics of matter by manipulation and control at the nanoscale. As
they cross many disciplines, also many industrial and technology chains, nanotechnologies are reshaping existing organizational
arrangements. Nano R&D requires a large degree of integration, from convergence of research disciplines in new ﬁelds of inquiry,
to new linkages among R&D labs, multinationals and start-ups, and a panoply of stakeholders.
Nanotechnologies, and other NESTs, have the potential to inﬂuence many value chains, create new ones, and will
co-evolve with governance processes (markets, regulation, user practices etc.). The ﬁeld is new; with limited history which
complicates trend extrapolation, and there are relatively limited applications in the marketplace. In addition nanotechnologies
can be novel themselves, or they can augment existing technologies, and even reinvigorate previously dormant technology
developments.
Decision makers interested in developing targeted research and innovation policy, or industrial strategies for that matter,
require support in capturing, sorting and distinguishing the actual developments in a particular technology or product application
area from the plans and promises (including expectations) in circulation. Forecasting NEST innovation pathways poses a
considerable challenge for FTA practitioners.
1.1. A tailored approach
For innovation to succeed in areas like nanotechnology, actor alignment from the research laboratory to product development
and eventual application area is necessary. Alignment is easier to achieve where the technology ﬁeld is well understood; the
actors are known, with their relationships already functioning; and where regulation is largely unambiguous. This is the case
with incremental innovation in established technological paradigms. For NESTs, such as micro/nanotechnologies where
architectural (radical) innovations might occur, conditions of non-linearity and high technology and market uncertainty are
typical [1–3].
Despite the high uncertainty, decision makers need to identify possible directions and promising options. Supporting them
presents challenges for current strategic technology intelligence and forward-looking assessment tools.
A promising approach to do this, which is sensitive to the complexities of emergence of NESTs, is that of capturing and
exploring multiple potential innovation pathways [4,5]. In our approach of Forecasting Innovation Pathways (“FIP”), indicators of
developments in the ﬁeld of technology are ascertained and explored to identify path dependencies. Such pathways may be broad
and tentative, but offer opportunities for insights into shared expectations [6], and emerging stabilizations in the technology
development processes. These can be brought together to identify endogenous futures — because there are emerging
irreversibilities in ongoing socio-technical developments, based on plans and other forms of shared agendas, mutual dependencies
and network ties. Pathways from the present to the future are based on the dynamics of the present – this means there are
“endogenous futures” [7] embedded in the present which can give indications and insights into the transition from present into
future – even if capturing these indications is a formidable challenge.
Such an approach relies on awareness of the rapidly evolving nature of the ﬁeld and smart ways of capturing a large amount of
data sufﬁcient to ascertain the dynamics of emergence. A characteristic feature of NESTs is that data are often located in a variety of
pockets, and are often heterogeneous in nature— a consequence of the NEST being at a nascent stage of development. Keeping this
inmind, any FTA tailored for a NEST should combine empirical and expert information resources to capture indications of potential
innovation pathways if it is to be effective.
2. Towards an FIP framework for NESTs
In order to create a framework for capturing indications of endogenous futures, we distinguish distinct aspects that help us
formulate requirements for an FIP analytical system:
(1) How best to capture the NEST's development situation? Many existing FTA approaches focus on exploring future
possibilities, neglecting to make sure that we understand key “forces and factors” of the current situation [8–10].
(2) How to build upon the current analyses to address the emergence and evolution of the ﬁeld? Which dynamics are
important? — This has implications for point 1. What sorts of data and analyses are needed [11] for evaluating emerging
ﬁelds of technology? — This has implications for the following point 3 as well.
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(3) How best to evaluate the analyses described above?Most FTA approaches favor expert engagement, but identifying experts
is a non-trivial task. In many cases, the types of actors to be engaged vary. Therefore there is a requirement to translate the
analysis from point 2 into useful intelligence to feed into multi-actor engagement approaches.
(4) How do we translate the evaluations into concise, but still rich, reports for use by the target decision makers [12,13]?
These four points summarize many complex practical issues.
In their portfolio of activities, we have explored each of these four requirements, in different contexts and in projects that lean
variously on some elements rather than others.We draw on these experiences, in particular two illustrative projects, to ﬂesh out
the FIP requirements. Our intent is to develop a framework that can both be used to put existing tools to work, and to identify
weak spots in the current FTA toolset. Comparing notes from our various projects, we created the system in Fig. 1.
The remainder of the paper will ﬂesh out some potential tools in the context of two case studies that show contributions in
different regions of the system. In the ﬁrst case, investigating nanobiosensors, the analysis is richer in most steps in Stages 1 and 2
(Steps A, B, C, D, and E). In the second case, of deep brain stimulation technologies, the study provides insights for Stages 3 and 4
(Steps F, G, H, I and J).
Following the description of these “case vignettes,” we discuss a palette of tools that could be put to work in such a system.
2.1. The FIP framework
The FIP framework includes four stages: (1) Understand, (2) Proﬁle and Link, (3) Project and Assess and (4) Report, and can be
further divided into ten steps. It should be noted that Step J – Engage Experts – begins in the ﬁrst stage and ideally would continue
to occur throughout all stages, identifying and persuading knowledgeable technical and contextual (e.g., business, markets, policy)
persons to assist in the process. Preferably on an ongoing basis, they help formulate data search processes, inform analyses, and
interpret results over the course of the study. Such key informants are important if the process and eventual output of the FIP
process is to remain close to real-time activities in the ﬁeld. Sometimes the FTA analysts are themselves highly conversant with the
technology; that certainly facilitates FIP.
Stage 1 serves to understand a technology's level of maturation and the contextual dynamics that could affect its potential
innovation pathways. There are different ways to characterize stages of technology development. For example, Technology
Readiness Level (“TRL”) [14] is a measure which is used by some United States government agencies and many of the world's
major companies (and agencies) to assess the maturity of evolving technologies. NESTs could be categorized by the status of
technology itself and its application markets. As we know, technology and society are interrelated, and they co-evolve [15,16].
Various representations of such “systems” address the socio-technical interactions for emerging innovations [17,18]. In this paper,
we use the Technology Delivery System (“TDS”) approach to reﬂect contextual dynamics because of its suitability for “emerging”
technologies by distinguishing: 1) the enterprise to develop the innovation and take it to market, and 2) the key contextual factors
affecting the success of that innovation process.
Stage 2 builds on empirical characterizations toproﬁle R&Dand link topotential applications.We search forR&Dactivity in suitable
Science, Technology & Innovation (“ST&I”) databases, andproﬁle the activity and actors from these data (Steps C andD).We then shift
to ﬁguring out how technological characteristics link to functional advantages, applications, and potential users (Step E). There are
many analytical tools to help proﬁle R&D, including bibliometric analyses, social network analyses, and trend analyses. We can adopt
or adapt them to facilitate our study as a function of the NEST state of development and the desired innovation indicators.
Stage 3 brings expertise to bear on the empirical results. Convening a workshop with multiple perspectives can anchor Step G
explorations of possible futures. Step F digests the prior results to present those to the participating experts and stakeholders. Step
H follows the workshop to assess the technology in two ways. First, we evaluate how the technology stacks up against alternative
means to deliver comparable functionality. Second, we perform impact assessment to delineate the ‘indirect, unintended, and
delayed’ implications of the projected development elements, resulting products, and their life cycles.
Stage 4 consists of integration and communication. Step I synthesizes what has been revealed about alternative innovation
pathways. It communicates ﬁndings to the target users. This may entail presenting the ﬁndings inmultiplemedia forms (including
interactive modes) and/or an additional diagnosis based on the ﬁndings leading to the generation of recommendations.
3. Two illustrative cases
In the following we report on the two case vignettes. They will be described in terms of the stages shown in Fig. 1, with
differing emphases.
3.1. Case study 1: nanobiosensors
Biosensors have been in development for more than a half-century, but only in the last decade have commercial applications,
augmented by a number of other enabling technologies, become available to any signiﬁcant degree. To date, few biosensors based
on nanomaterials are at an advanced stage of commercialization; meanwhile, anticipation of the potential of nanobiosensors is
garnering great interest in three application domains: healthcare, environmental monitoring, and agrifoods. Of the three,
healthcare is receiving the most interest from industrial actors. Nanobiosensors will also likely be involved in other potential
markets — such as homeland security and defense.
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Fig. 1. Framework to forecast NEST innovation pathways.
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Nanobiosensors constitute an area promising a vast array of potential applications, but high uncertainty on where (and if) they
will enter the market, speculation on what sort of support they will need (including desirable governance modes). The ever
increasing interest with regards to promising applications is mirrored in the world of research were we have seen a steep increase
in research activity reported in the scientiﬁc peer-reviewed press.
For our aim of further developing the FIP framework, nanobiosensors offer an interesting case to capture and explore emerging
innovation pathways. We highlight activities pertaining to the four stages described in Section 2 of our framework (Fig. 1).
3.1.1. Understand: understand the NEST and its TDS
In general, we could divide NESTs into two types according to the status of their applications: 1) emerging technologies where
applications are still very speculative (no actual applications on the market); and 2) emerging technologies with some
applications in the market.
The ﬁrst type of NEST shows research with minimal focus on applications — i.e., mainly fundamental, not applied. Data on
potential applications can be captured in this ﬁeld (see Box 1) but speculations about applications are between Sci-Fi and Guiding
vision [29]. The second NEST type includes R&D that begins to note applications that may not be well deﬁned yet, or others with
application areas that are well developed, but amenable to notable enhancement. Here, anticipation of potential applications lies
between Guiding Vision and Proof in the Box 1 classiﬁcation scheme. Nanobiosensors would be located in this second type because
there are some applications in the ﬁeld of healthcare and pharmacy already.5
To undertake the Technology Delivery System (TDS) analysis, we have operationalized two perspectives to model this complex
system to realize the elements in the journey along the road from R&D toward commercial (or other) innovation [19].
“Push-to-Pull Enterprise Analyses” are used to identify the key players and their requirements to make prospective technological
innovation occur. “Contextual Forces & Factors Analyses” uncover factors that will drive innovation in particular ways, including
any barriers that could hinder particular developments.
Following this, in the ﬁrst stage of the project, we identiﬁed which elements (actors, infrastructure and interactions) are
necessary to “deliver” nanobiosensor applications to the market and for them to be taken up and be used in society. Modeling of
the TDS [3], involves multiple perspectives, including identifying R&D activities, institutional involvements, major actors, and key
markets. To anticipate the potential avenues of development within the ﬁeld of nanobiosensors, it is also essential to identify
interactions among players and to explore potential supports and barriers in the environment.
In devising a TDS model for this case, we emphasized the situation and institutions of the United States — a world leader in
biosensor research. In Fig. 2, through expert engagement and document analysis, we created a ﬁrst round socio-technical system
composed of institutions directly or indirectly involved in the development of nanobiosensor technology. At the societal level, we
categorized four key player types: Governments, R&D groups, Manufacturers, and Users.
The TDS includes the key actors. Various government entities are (or could be) involved in addressing social, political, and
economic aspects related to this new technology. In relation to R&D funding, we observe two levels:
Federal agencies, which provide the major share of support — such as the National Science Foundation (NSF), Environmental
Protection Agency (EPA), Department of Energy (DOE), and National Institutes of Health (NIH).
State agencies also contribute to R&D support with relatively smaller shares (e.g., constructing new nano research facilities at
universities, including Georgia Tech).
Since nanobiosensor applications relate strongly to food and healthcare markets, relevant agencies are involved in regulating
product development, like the CDC (Centers for Disease Control and Prevention), the USDA (U.S. Department of Agriculture), and,
especially, the FDA (Food and Drug Administration). Examples of large funding organizations include the DOD (Department of
Defense) and the DHS (Department of Homeland Security), which places an emphasis on early applications in detection for
security. These agencies may provide a market as well — i.e., government purchasing could act as an initial client and in this way,
provide an incentive for particular innovation pathways.
Research in the nanosciences and nanotechnologies is highly multidisciplinary; this is visible in nanobiosensor R&D groups
whose activities entail the integration of material sciences, molecular engineering, chemistry, biotechnology, and electrical
engineering. In addition to the academic and non-proﬁt/governmental research effort, some of themajor biosensor companies are
engaged in R&D programs related to nano.
Manufacturers of nanobiosensors in the US can be divided into three groups: (1) specialized manufacturers, (2) start-up and small
manufacturers, and (3) large national or multinational companies. In the current early stages of nanobiosensors, start-up companies are
themost active in development,most ofwhich are funded via venture capital anduniversity spin-off support. An important characteristic
for the ﬁeld of nanobiosensors is that their technological development and manufacture are strongly linked to universities.
A ﬁrst step for us was to identify the important issues in the TDS which need to be ascertained to allow us to evaluate the ﬁeld.
Understanding the NEST developmental situation provides a general sense of the key actors, interests, and potential innovations.
Such an understanding helps the analyst to specify the key technology management issues. Table 1 offers a set of such issues from
which to choose. It must be pointed out that these issues can vary widely, depending on the technology itself, its particular
contextual situation, and the particular interests of the intended users of the FTA [20].
5 For example a number of (relatively) simple nanobioarrays have been produced which follow on from the well embedded microbioarrays. As the ﬁeld moves
closer to more complex, and multi-component nanobiosensors, the variety and scope of potential applications increases.
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Based on the nanobiosensor development situation, we identify our case study's key Management of Technology (“MOT”)
issues (Table 1) as:
I. Collaboration in technology development, and
K. Tracking and forecasting emerging or breakthrough technologies (opportunities and threats)
These translate into target MOT questions to address for nanobiosensor innovation prospects:
• What are the key nanotechnologies/nanomaterials?
• What are key technologies' competing functions?
• Which countries are the research leaders?
• Which organizations are the research champions?
• Which at the main academic and industrial connections for those organizations?
• Which sub-topics are garnering the most attention and by whom?
• What are the most promising pathways for future commercialization?
Following this, we specify innovation indicators to address these MOT questions. Because nano-enhanced biosensors could
improve existing biosensor applications, it's very important to identify their commercialization opportunities at this stage. In this
Box 1
Classifying speculations on applications.
In a special issue on Nanotechnology in the Journal of Scientometrics, Robinson, Ruivenkamp and Rip [30] categorize the
strength of statements made about nanotechnology applications in the world of R&D. They distinguish six categories to
locate the forms of speculation, and the evolution over time. Such a taxonomy can disentangle the different forms of
anticipatory coordination in a ﬁeld of R&D through analysis of statements made by experts either in texts or in interviews.
The six categories are: (1) Science Fiction (it may happen accepted as fantasy), (2) Visionary Statements (it may happen but
accepted as a reality based fantasy), (3) Guiding Vision (it may happen and we include that in our repertoire of possible
directions), (4) Expectations (it will happen), (5) Agendas (We are going to make it happen) and (6) Proof (it is proven and/
or demonstrated).
The spread or concentration of statements across this scale, and in certain communities, can help get a keener grasp on
future-oriented statements and expectations for a target NEST.
Fig. 2. Nanobiosensor TDS for the USA.
272 D.K.R. Robinson et al. / Technological Forecasting & Social Change 80 (2013) 267–285
way, we focus more on commercialization aspects, especially the connection between R&D and applications. The main indicators
that were generated for this case study lead to the following requirements:
• Locate nanobiosensor research on the map of science
• Map collaborations, with a view to identifying pointers toward potential commercial development
• Compare national R&D efforts, as an indication of commercialization strengths
• Develop a matrix of leading companies with topical research and patenting emphases
• Cross-chart nanostructured materials with functions and potential applications
This provides the entrance point for digging deeper into the ﬁeld.
3.1.2. Proﬁle and link: proﬁle R&D and link to potential applications
Once these indicators have been articulated, the next step is the detailed proﬁlingwork – Stage 2 in Fig. 1 – “Proﬁle and Link.” Stage
2 leads us toward three elements of FIP: Proﬁle R&D, Proﬁle innovation actors and activities, and Determine potential applications.
Here, we adapt existing analytical tools to facilitate our R&D study. At the same time, we have devised the process of
“S&T-Function-Application Cross-Charting” to visualize the bridges across the gap between R&D and Applications. This is vital to
understand how particular technologies might link to potential applications.
In our nanobiosensors case, we began with the assumption that “nano” could contribute to biosensors. After analyzing sets of
R&D article abstracts and interacting with nanobiosensor researchers, we found it helpful to systematically array the attributes of
the technology (here, the features that nano offers) in terms of functional advantages, and, in turn, how those functions could
translate into enhanced applications.
In this study and in companion analyses of nano-enhanced solar cells [21], we have found value in:
(1) Subdividing the technical elements (e.g., distinguishing among various nanostructured materials);
(2) Engaging with those knowledgeable about the technology through the process of further specifying the set of important,
and distinctive, functions;
(3) Exploring which functions pertain to particular applications (in some cases requiring partitioning functions and/or
application sets);
(4) Considering links between applications and commercial opportunities (users, sectors, etc.).
Later in this section we explore the results of this stage of the project (Fig. 4). The main dataset in this case study comes from
global nanotechnology research publications for the time period 2001 through 2008 (part year) extracted from the Science
Citation Index (“SCI”), from which we have extracted 1400 records pertaining to nanobiosensors.
3.1.2.1. Exploring R&D multidisciplinary aspects. We applied science overlay mapping [22] to locate nanobiosensor R&D among the
disciplines. This approach uses the Subject Categories that Web of Science assigns to journals. So, for a set of publications indexed
byWeb of Science (in this case, by the Science Citation Index, SCI, which is part of Web of Science), we locate this research via the
journals in which it appears. Fig. 3 overlays nanobiosensor research over a base map reﬂecting the 175 Subject Categories shown
by the background intersecting arcs. The Subject Categories are grouped into “macro-disciplines” using Principal Components
Analysis based on the degree of co-citation of the Subject Categories in a large sample of articles indexed byWeb of Science. Those
macro-disciplines become the labels in the ﬁgure. The nanobiosensor research concentrations appear as nodes in the map, with
larger nodes reﬂecting greater numbers of publications.
Fig. 3 illustrates that global nanobiosensor research involves a very extensive range of research ﬁelds. It is concentrated in the
Materials Science and Chemistry macro-disciplines, also involving a number of Biomedical Sciences and various other ﬁelds. This
analysis helps understand the S&T ﬁelds involved, to help identify technical experts.
Table 1
Technology management issues and concerns (Source: Tech Mining [21]).
R&D portfolio selection
R&D project initiation
Engineering project initiation
New product development
New market development
Mergers
Acquisitions of intellectual property (“IP”)
Exploiting one's own intellectual assets
Collaboration in technology development
Identifying and assessing competing organizations
Tracking and forecasting emerging or breakthrough technologies
(opportunities and threats)
Strategic technology planning
Technology roadmapping
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3.1.2.2. Exploring R&D to application connections. A general “cross-chart” from fundamental nanotechnology tomarket applications
(Fig. 4) reveals vital links among nanostructured materials, biosensors, and applications. It also explores the underlying functions
of how nanomaterials can enhance biosensors, which can help future innovation path mapping.
Fig. 4. General nanobiosensor technology — application cross-chart.
Cognitive Sci
Computer Sci
Geosciences
Agri Sci
Ecol Sci
Chemistry
Physics
Engr Sci
Mtls Sci
Infectious Diseases
Clinical Med
Health Sci
Env Sci & Tech
Biomed Sci.
Fig. 3. Locating worldwide nanobiosensor research over a base map of science (Database: SCI).
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In generating Fig. 4, we sought to identify the added value of nanostructured materials for biosensors (“nanobiosensors”).
Structures at the nanoscale can provide advantages over the samematerial used at a coarser scale.6 Cross-charting helps elucidate
how particular nanostructures7 enable functionalities that can enhance particular applications.
Nanostructured materials can contribute to the biorecognition element, the transducer of a biosensor, or both. The functions of
nanomaterials used in biorecognition can be divided into two classes. The ﬁrst class is referred to as “target labeling” using “0D”
(zero-dimensional) or “1D” (one-dimensional) nanostructured materials (e.g., semiconductor nanoparticles). For this
nanobiosensing system, nanostructures are ﬁxed to the biomolecules (or species) that are to be sensed.
The second class of nanomaterial functions used in biorecognition is mainly in the form of replacing the traditional molecular
recognition layers. This takes the form of 2D or 3D structures (or constructs) upon which a biomolecule will interact (think of a
liquid ﬂowing across a plate, or through a sieve — the nanobiosensing elements will be ﬁxed to the plate or sieve and detect the
biomolecules in the liquid).
These are two broad generalizations of the two classes of biosensor and you can imagine that with the variety of nanoscale
constructs and functionalities of nanoparticles and quantum dots, plus a variety of materials, the ﬁeld of nanobiosensors is
inherently diverse and could potentially enable many applications in a variety of sectors.
In the cross-chart analysis, the left-hand-side allows us to see if certain nanostructures contribute to particular functions
that are essential for speciﬁc applications. Conversely it can also show where there are gaps in solutions (or R&D) for a
particular biosensor application.8
For instance, the use of 3D nanostructures might only be applied to a limited subset of functions that contribute to only one or
two types of biosensors. The next steps could then key in on the organizations focusing on that cluster of innovation pathway.
Results do not localize neatly (Fig. 4) but do give an indication of the clusters of innovation pathways that are under development,
and can help direct the next steps of the FIP framework.
Note also that several typesof nanostructures aremore suited toprovidingparticular functionsover others. For example, ifwewanted
to “zoom in” on one type of biosensor (e.g., thermal), Fig. 4would orient us toward particular gains (e.g., patents pertaining to enhanced
heat transfer or binding capacity). We highlight with thicker arrows in Fig. 4 the cluster of paths that lead to a particular biosensor
(magnetic biosensor) and the most promising application (i.e., that which is most touted in the literature and from our interviews).
Another way is to look at a speciﬁc nanostructured material. The dotted arrows trace two pathways that are part of the cluster of
activities that stems from thin ﬁlms. One pathway leads to electrochemical sensors [30–32]. The potential advantage of such
nanoparticles dispersed through polymer ﬁlms as an electrochemical nanobiosensor is that the distribution (as well as the
nanoparticle size and type) can be controlled based on the type and processing of the polymermatrix. These dispersions in thin ﬁlms
provide conductivity improvements by orders of magnitude (excellent for detecting minute traces of toxic substances).
Another pathway indicated links thin ﬁlms to piezo-electronic sensors. Thin ﬁlms offer unique advantages for piezo-electric
sensors, overcoming some of the technical barriers to providing this functionality (such as creating the desired structures, and at a
relatively low cost) [33]. Applications of this technology include detection of microorganisms such as Salmonella, Escherichia Coli,
and Staphylococcus aureus.
The cross-chart is a useful representation, as it allows the analyst to move back from an application to potential nanostructures,
or vice versa. Or, one could start from the middle, focusing on a particular nanobiosensor (such as optical biosensing) to explore
downstream toward applications and, then, market segments; and/or upstream, toward key contributing research topics.
Cross-charting can also help spotlight a particular community of research and industrial actors.
3.1.2.3. Exploring commercialization of nanobiosensors. To explore the nanobiosensor commercialization prospects, a list of the
leading corporations around the world is provided in Table 2 (based on research publications, as indexed in SCI). From this table,
we can see the countries with active industry involvement include the USA, China, Germany, Japan, Canada, and Sweden. Although
the no. 1 company in the list is American, we conclude that industrial R&D on nanobiosensors is led by Japanese companies, with 5
companies in the top 15. Therefore we use Japan as our initial focus to explore leading edge commercialization.
3.1.2.4. Capturing early signals of intent to commercialize. The map in Fig. 5 explores co-authoring among the top corporations and
other R&D organizations in Japan. This can help answer a number of important questions: Are there networks among the key
nanobiosensor research groups? How are the industry players networkingwith other R&D organizations?What are such networks
emphasizing? Some observations:
(1) A relatively large number of Japanese corporations are publishing on nanobiosensor research;
(2) We can observe notable cooperation between industry–industry and industry–academic organizations within Japan;
(3) Academic organizations provide the core of these research networks, connecting several corporations (as circled in red in Fig. 5);
6 Nanoscale structures are similar in size to the biomolecules that are to be sensed. Biomolecules can range from 10s to 100s of nanometers and it is this
advantage, creating structures that have the same resolution as the study object, which makes nanotechnology so promising for biosensors. Developments in
nanobiosensing are already unveiling information about the interactions of biomolecules with other complex biomolecules, such as enzymes and other proteins,
antibodies, DNA, RNA, and larger biological species such as organelles or cells.
7 A variable that, through our earlier analytical steps, we found to be one of the key characteristics which determine a variety of biosensor functionalities.
8 This is dependent on the goal of the exercise. The theme of this project was to locate which nanostructures are being researched and how they connect to
biosensing applications. A next step could be to identify the gaps in the cross-chart (i.e. linkages/arrows that are not being explored).
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Fig. 5. Cooperation between companies and other organizations in Japanese nanobiosensor research (Database: SCI).
Table 2
Top 15 nanobiosensor corporations in the world (Database SCI).
No. #Records Afﬁliation Country
1 13 Geocenters Inc USA
2 11 Wuhan Iron & Steel Co China
3 10 KFA Julich GmbH Germany
4 8 Nanomix Inc USA
5 6 BAS Co Ltd Japan
6 6 Japan Sci & Technol Corp Japan
7 5 FONA Technol Inc Canada
8 5 Siemens AG Germany
9 4 Biacore AB Sweden
10 4 Ebiochip Syst GmbH Germany
11 4 Eicom Ltd Japan
12 4 NTT Adv Technol Japan
13 3 Abgenix Inc USA
14 3 Cent Res Labs Ltd England
15 3 Hitachi Ltd Japan
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(4) The key academic organizations that are engagedwith industry include: KeioUniversity, KyushuUniversity, University of Tokyo,
National Institute of Advanced Industrial Science & Technology, Tokyo University of Technology, and University of Tsukuba.
In addition, we also investigated more deeply to ﬁnd what these networks are doing through text analysis of their
co-authored papers.
(1) The network around Keio University: has a focus on the enhancement of biosensor sensitivity via improving catalytic ability
of nanoparticles in electrochemical sensing [23];
(2) The network around Kyushu University: has a focus on the enhancement of biosensor sensitivity via usingmagnetic ﬁelds of
magnetic nanoparticles [24];
(3) The network around the University of Tokyo: focus on the enhancement of SPR biosensor sensitivity and stability via using
thin ﬁlm and SAM (a 2D nanostructure) [25];
(4) The network around the National Institute of Advanced Industrial Science & Technology: focus on the enhancement of
biosensor sensitivity via taking advantage of the biocompatibility of polymer nanoparticles in mass/piezoelectric sensing [26].
3.1.3. Project and assess prospective innovation pathways
This stage was conducted in two rounds. The ﬁrst round involved face-to-face interviews with researchers at Georgia Institute
of Technology (US), which provided input to allow a ﬁrst evaluation of our analyses. The second round entailed a campus
workshop (~10 participants including ~5 with particular knowledge in nanomaterials, biomolecular engineering, and biosensing).
This focused onmapping likely innovation avenues, following the process described and demonstrated by Robinson and Propp [4].
We then called upon our experts again to review our interpretations from the workshop. In the future, we should engage persons
knowledgeable in broader innovation aspects, including production, regulation, marketing, and use.
3.1.4. Report: usable output for decision support
Based on these analyses and inputs from the workshop in Stage 3, we constructed two potential innovation avenues. Here we
refer to the two approaches as FIP-1 and FIP-2.
FIP-1 is based on the roles of nanostructured materials in biosensors. Two different innovation avenues identiﬁed are:
Pathway 1. Enhancing biorecognition/bioconjugation using nanostructured materials in biosensors. In general, this path uses
nanomaterials passively, that is it focuses on surface properties, such as surface to volume ratio, surface afﬁnity, and selectivity to
biomolecules and cells.
Pathway 2. Enhancing signal transduction or creating new transduction mechanisms using nanomaterials in biosensors. In
general, this pathway seeks to utilize nanomaterials, in a more active way, taking advantage of unique properties of materials with
nanoscale dimensions, such as quantum effects, piezoelectric effect, etc.
Fig. 6. First rough multi-path map to identify the relevant axes and issues for the DBS project.
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FIP-2 is based on differences in the sensing target. Here, we identify three different paths taking advantage of nanomaterial
enhancements:
• Pathway 1: cell-based sensing
• Pathway 2: sensing macromolecules, such as proteins and DNA
• Pathway 3: sensing small chemical molecules such as Fe, O2, etc.
The 1st of these focuses on sensing the behaviors of whole cells without knowing detailed information about the sub-cellular
matrix, organelles and metabolic pathways. The 2nd path senses by probing biomolecular interactions, either on the cell
membranes or inside the cell bodies themselves. The 3rd path emphasizes the presence and concentration level of biologically
relevant chemical substances. All three innovation pathways may use nanomaterials either passively or actively.
At the time of writing we are still developing these potential Innovation Pathways. Such charts and maps should address
speciﬁc key nanomaterials or nanotechnologies, and the particular obstacles, along every path.We didn't explore Stage 4 to the full
extent in this case study. Further innovation pathway development should be tailored to meet particular technology management
interests.
To gain insights for the latter stages of the FIP framework, the following case vignette describes a different NEST FIP situation,
and places more emphasis on describing these latter stages.
3.2. Case study 2: deep brain interface devices
In this project, the objective was not to capture a whole ﬁeld, but to explore the potential technological paths that a particular
research institution could/should take in relation to its nascent nanotechnology-bioelectronics research program. The
organization had a broad idea of what the next 10 years of technical research in nanotechnology/bio-electronics may look like
but also articulated its wish to further explore new areas, such as interfacing with brain functioning. In addition, as part of its
strategic research drive, it wished to explore medical applications at an early stage and use this to help guide R&D. The key
question was, therefore, how to enhance current interfacing of technology with brain functions (including one-way stimulation
approaches) through targeting the institute's research in nanotechnology and bioelectronics.9
With this in mind, a key element was to forecast potential innovation pathways to evaluate the ways that the technology could
co-evolve with regulation, markets, patients' perspectives and demands, clinical practice, etc. — in order to identify suitable
strategies. In the following we track through case highlights with respect to the four stages of our FIP framework (Fig. 1).
3.2.1. Understand: understand the NEST and its TDS
The trigger for this project came from a research group leader about to embark on creating a portfolio of application-oriented
research projects with the broad (and as yet unarticulated) vision of the research program leading to a closed-loop-implant
system for the brain.10 The researchers realized that as a micro/nanoelectronics center wishing to develop technologies for
interfacing with the brain, they would need support in exploring the potential innovation pathways that could be pursued.
Consequently, they wished to speculate in a controlled way on the possible pathways that would (a) deliver innovative
technologies (in-line with their institute objectives), (b) be optimized for uptake in healthcare practices, and (c) would be in line
with the EU Nano Action Plan (“responsible innovation” was a key driver in this group).
Their ﬁrst idea was to target their R&D agenda to improve current capabilities in stimulating the brain, and to target their
activities in the area of deep-brain stimulation (“DBS”) for physical and psychological disorders. The next steps would create a
smart self-managing implant. DBS – currently a niche technology – is seen bymany to be on the verge of wider application, leading
to an external interest from neurosurgeons, medical device manufacturers and regulators— and hence was a great opportunity for
FIP methodology development.
At the time of this FIP project, DBS (a 4-point electrode with stimulating signal ﬁxed during direct physical access to the brain
after removal of skull cap) was under clinical investigation for a broad selection of neurological and psychiatric conditions, such as
epilepsy, dystonia, Tourette's syndrome, depression, obsessive–compulsive disorder, and cluster headache.
Although knowledge of themechanism of action of DBS is limited, developments to improve and reﬁne the stimulation process
are underway, augmented by technological advances in ﬁelds such as micro- and nano-fabrication, imaging, and improvement of
stereotactic methods, to name but a few lines of investigation. Still a niche technology, with applications to patients who have no
alternative therapy, the promise of DBS has prompted industrial development in Parkinson's (Medtronic), epilepsy (Medtronic
and Neuropace), and in other disorders too.
The situation for the R&D group wishing to create a 10-year plan translated into a 1st round multi-path perspective shown in
Fig. 6 (created together in early interviews prior to the commencement of the project). Located at the bottom of the Y-axis, the
research institute wished to place on their research agenda new technology development that would link up with innovation
9 This FIP exercise was organized as part of a constructive technology assessment project within a European R&D network for nanotechnology for the life
sciences. Constructive Technology Assessment (“Constructive TA”) is a support tool for reﬂexive co-evolution of technology and society which takes as its
starting point ongoing and evolving socio-technical dynamics and those emerging irreversibilities that crystallize out in the evolution of NESTs.
10 Closed-loop means that the system stimulates the brain, records the changes in brain functioning and adapts further electronic stimulations through real-
time analysis of the data (without human intervention). Open-loop systems mean there is no reactivity of the device, i.e. the electronic pulse rate and level of
electro-stimulation remains constant. Open-loop systems are the current stat-of-the-art, where the pulse rate is ﬁxed during the actual operation of implanting
the electro-stimulation device into the brain.
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pathways in the area. Thus they needed to get a handle on the situation at all stages of development (up the Y-axis) and speculate
how these would evolve over the next 10–15 years. This initiated the FIP exercise.
The mapping activity looks for strong and weak signals as indicators of patterns and directions in the emerging ﬁeld and is
broken down into three steps. Step 1 is the mapping of the network of actors and linkages among them. Step 2 involves the
exploration of anticipatory expectations that shape the strategies and action of these potential stakeholders [5]. Such analysis of
expectations (see Box 1 earlier) can provide strategic intelligence on weak signals of emerging paths and trends. Step 3 involves
ﬁnding indication of emerging structures, path dependencies and other entanglements which are shaping the activities in the ﬁeld
[1]. These emerging entanglements, path dependencies and forceful expectations add up to endogenous futures.
All three of these are important to map possible innovation pathways and understand the various dynamics at play. The
socio-technical mapping helps describe the landscape of actors and other key elements in the ﬁeld, the relationships and
dynamics.
In interviews (and in their strategic agendas) we observed that technology developers projected futures and worked with
them to guide their design and experimentation activities. They articulated requirements based on this vision of the future and set
out milestones (or in large projects, create roadmaps) to guide the design, development and optimization.
Even though, in actual practice, technology developers (especially those designing, developing and optimizing) observe that
the path to innovation is far from linear with many twists, turns and setbacks, they still use a linear, chain-like model:
• To project paths to follow
• To draw boundaries on requirements to be fulﬁlled, based on the vision of applications and expectations on others involved in
the development process, their roles and responsibilities.
To capture the non-linearity of innovation processes, the metaphor of the ‘innovation journey’ has been used to reveal the
complex twists in the emergence of a new product [27]. The innovation journey idea of Van de Ven, which has been picked up
elsewhere in technologymanagement circles, is a way of re-framing notions and premises of innovation dynamics— innovation is
non-linear and characterized by learning processes of actors about artifacts and actants.
A schematic innovation journey was put forth by Voss [28] to highlight key elements, (multiple) origins, coupling, forks, shifts,
setbacks (up to halting the journey), and projections. This diagram is quite useful but it also makes clear a tension for FIP. From an
observational standpoint we have recognized that innovation is de facto recursive learning, but from amanagement point of view,
it needs to be managed efﬁciently. How to reconcile?
The ﬁrst step is to embrace these complexities with a deeper understanding of innovation journeys, and the endogenous
futures that become more visible as the journey progresses. The second step is to identify loci for inﬂuencing the dynamics of
innovation emergence. These have been core research lines in the ﬁeld of constructive technology assessment.11
For this FIP project, the idea was to capture the complex activities and dynamics in the evolving ﬁeld of deep brain stimulation,
to explore themwith relevant experts, and to translate these ﬁndings back into the perspective of the technology developers, who
in their everyday practice rely on roadmaps and linear projections.12
We developed the innovation chain (“IC”) as an FIP tool to start a process of broadening the linear model to a chain of arenas of
development of the technology (note actors are not placed in this diagram; it is amatter of activities). The ﬁnal IC result can be seen in
Fig. 7.
(1) The IC brushes over the actual details of the technology development process of DBS in that it does not show the differences
amongexistingor emergingplatformsor solutions. For example, there is nodistinctionbetweenopen-and closed-loop systems
(while there is a distinction in terms of the exploitation paths of integrated devices: i.e., going quickly for niche applications, or
focusing on generic devices). Thus another style chart is necessary as an output of the FIP exercise. The TDS is here transformed
into a chain of innovation steps, arenas of action that will shape the development of the technology.
(2) The IC is also autonomous with regard to time. Progress at research level can, over time, lead to completely new prospects of
technological exploitation; hence the chains of the IC diagram could relate to fundamentally different kinds of activities.
What the IC diagram allows is quick identiﬁcation of R&D and product introduction challenges within the broader context of
economic (competition), societal, ethical and consumer, and expectations-related issues.
By this stagewe have identiﬁed themain actors, the arenas of activity and themechanisms of assessment of our target audience
(technology developers trying to identify a more robust roadmapping style agenda). The next step was to dig deeper into this data
to identify the endogenous futures and innovation journey dynamics, and translate this into something that can be explored and
evaluated by experts in the ﬁeld (in the move towards a ﬁnal usable output).
3.2.2. Proﬁle and link: proﬁle R&D and link to potential applications
The next stepwas to translate the previous ﬁndings intomaterial that could be evaluated by relevant (potential) stakeholders.We
chose the approach of socio-technical scenarios as a means of synthesizing and presenting the data gathered from stage 1 of the FIP
approach.
Socio-technical scenarios combine a large number of elements and dynamics relating to potential innovation chains. These
translate endogenous futures into scenarios which not only take actors' initiatives and interactions into account, but also the
11 This has also been extended through a form of constructive technology assessment known as Strategic Niche Management (SNM).
12 Therefore, the starting question and output of the workshop used this chain-like notion as part of the framing of the strategic intelligence.
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surrounding or ensuing dynamics and shifts in agendas that slowly become irreversible. Scenarios are not used here to extrapolate
particular developments into the future. Rather, they provide insights into how plausible futures may unfold from the present,
constructed in narratives that reﬂect innovation journeys, they can present a complex story of the interplay of actor strategies,
technologies and infrastructures and other socio-technical linkages (and how they become stabilized over time).
The function is to present a collection of “playings out” of plausible, non-mutually exclusive innovation journeys to capture
complexities revealed by the in-depth analysis of the state-of-emergence, and so allowing a platform on which the interactive
workshop can build. The scenarios are structured around social studies of science and technology (notably STS and innovation studies)
and provide an opportunity for the workshop organizer to present dilemmas, choices to be made (in the form of forks), and actions.
One can also bring in elements from other cases as plausible contributors to the emerging innovation journeys described.
3.2.3. Project and assess: project and assess prospective innovation pathways
Workshops are key for bringing together knowledge from the above analysis with the experience and expertise of multiple
stakeholders. In addition they provide an opportunity for stakeholders to “probe each other's world perspectives,” share
knowledge, and collectively create new knowledge.
The DBS workshop ﬁrst focused on discussing the technology options, the scenarios, and elements that would shape potential
innovation pathways. This led to identiﬁcation of the key elements and issues. We also explored actor strategies (beginning with
scenario characters and moving to those in the real world). For DBS, we co-located large and small medical device manufacturers,
researchers and experimental neurosurgeons with the aim of exploring the various potential innovation journeys from laboratory
to wider clinical practice in motor and psychiatric disorders (such as Parkinson's, epilepsy and obsessive compulsive disorder).
One key aspect is the diversity of the participants. Recalling the Innovation Chain, we made sure that each arena of activity in
the innovation chain was covered in the participant lists. In this way a combination of scenarios, expert knowledge, and the gained
through the ﬁrst stage of the FIP process could be combined and fed into deliverables.
3.2.4. Report: usable output for decision support
In the workshop we discussed the major challenges faced by key actors along the innovation chain. To identify the key factors
that would shape development processes in this ﬁeld of technology, the innovation chain diagram was used to locate some key
issues (see Fig. 7). On the diagram, you can locate various stakeholder groups that will dominate that area of the innovation chain
and will be able to shape it most strongly. The participants in the workshop reﬂected this — experimental (innovation driven)
neurosurgeons, device manufacturers, techno start-ups and researchers. For this workshop the ﬁndings were translated into the
innovation chain diagram and a similar depiction, but including development details and a time aspect. For the latter, a number of
successive innovation avenues (generations) that in the workshop were deemed necessary in the move towards advanced, closed
loop, deep brain interface devices, are shown in Fig. 8.
Figs. 7 and 8 represent an important output for the project. The results of this FIP exercise have been drawn upon in the
agenda-setting activity of the group, who has now, at the time of writing, developed their 10 year R&D plan.
Through this FIP process, for DBS we have identiﬁed themany players and explored indicators of plausible futures. We translated
this information into scenarios. These scenarios were used to explore potential playing out of the development of DBS and thus
allowed identiﬁcation of the key dynamics, challenges and opportunities in near and mid-term futures. Such scenarios show various
actor positions and strategies, and allow discussions (especially in sensitive areas). In this case, the large and small ﬁrms involved in
the exercise could not discuss their own company strategies but could evaluate and respond to characters in the scenarios.
As an output, a usable form of intelligence for the actors was created, potential innovation avenues amidst a landscape of
challenges, opportunities, etc. In addition the innovation chain diagram revealed issues for particular arenas of development that
are crucial for the creation of an advanced DBS value chain. The two diagrams provide support for alignment of actors involved in
the Technology Delivery System.
4. Wrapping and opening up
In our two case studies, we operationalize tools developed in house for a number of steps in an FTA process emphasizing future
innovationpathways forNESTs.Whatwesee is commonality in the steps, even though theprojectswere initiated indifferent contexts.
The partitioning of assessment steps, from themenu of tools that may be applied, constitutes a system for tailoring the FTA to the
innovation context— leading to aﬂexible approach. Such aﬂexible approach is absolutely necessary for NESTs,wheremore often than
not, the formsofdata that are possible toobtainwill differ greatly. In addition the scopeof the FTAmaydiffer, for example in this paper,
we explore nanobiosensor developments at a national/international level, and thus have amacro-level perspective on the Technology
Delivery System. In the deep brain stimulation case, we explore the socio-technical system evolving aroundDBS technology, but focus
in on the micro-level of an R&D group's technology strategy considering innovation value chains.
Of key interest to the authors is productive combination of qualitative and quantitative tools in the Proﬁle, Project and Assess steps
of the approach. For the DBS case, qualitative tools were emphasized, requiring the FTA actor to spend a signiﬁcant amount of time in
the ﬁeld to gather the relevant indicators for constructing a socio-technical map and innovation chain. The richness of the data is
unquestionable, but labor-intensive.13 However for broader application of an FIP approach, other tools would be advantageous. The
13 For research purposes such deep qualitative investigations are worth the investment. In this case, it was part of PhD research into the co-evolution of
nanotechnology and society.
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Fig. 8. Simpliﬁed chart showing the main DBS innovation pathways with key issues and opportunities along these pathways.
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Table 3
FIP frameworks and candidate tools.
Step Analyses Candidate tools
State-of-emergence Step A: characterize the technology's nature ●Describe the technology and what it does Technology readiness levels
●Technology development stage analyses
Step B: model the TDS ●Contextual forces and factors analyses Socio-technical mapping
●Push-to-pull enterprise analyses Techno-economic networks
Fleshing out potentials Step C: proﬁle R&D ●Bibliometric analyses Tech mining
●Top actors and topic analyses Publication analyses
●R&D disciplinary analyses Patent analyses
Social network analyses
Trend analyses
Step D: proﬁle innovation actors and activities ●Enterprise cooperation analyses Cross charting matrix
Step E: determine potential applications ●Competing technologies analysis Data mining on co-authoring among top corporations
●Competitor, risk and market analyses Platform proﬁling
●Commercialization pathway exploration and assessment
●Reﬁned, speciﬁc opportunities analysis
Projecting and assessing futures Step F: layout alternative innovation pathways ●Consolidate Intelligence from Steps A–F Multi Path Mapping (1st round)
●Analysts nominate promising innovation paths (IPs) and contingencies Scenarios
Visualizations like TDS/Innovation Chain
Step G: explore innovation components ●Analyze IPs within key selection Interviews with multiple experts
Step H: technology assessment ●“Winning” potential innovation pathways impact assessment Multi-path mapping (2nd round based on Step G)
●Alternative technologies comparative impact assessment Innovation chain (2nd round)
Technology comparison matrix
Reporting Step I: synthesize and report ●Iterative review Papers
●Communicate ﬁndings (use multiple media; interactive as possible) Standard reports
Supporting Step J: engage experts ●Support to the analyses from Step A to Step I Interviews
Questionnaires
Workshops
Co-author papers
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nanobiosensor project shows some of the tools that can be applied, capturing the global data on nanobiosensor development and
ﬁnding indications of applications, indications of the intent to commercialize, etc. The scenarios, workshops and charts (themultipath
maps, innovation chain diagrams etc.) of the DBS enabled focusing on particularly relevant issues in the emerging ﬁeld.
To truly address strategy-relevant intelligence, a systematic framework for capturing and exploring potential innovation
pathways for NESTs is necessary. As we have outlined, we see that tools for smart capture of information, ﬂeshing out themodel of
the Technology Delivery System, identifying ﬁrst round potential innovation pathways, and then zooming into these through
augmented expert engagement exercises is an effective approach. In this paper, we have done this by drawing on a variety of tools
and approaches that have been emerging in Europe and the United States based around the concept of FTA and potential
innovation pathways as a means of forecasting and assessing the emergence of nanotechnologies.
Drawing on insights and lessons learned from the two case examples of nanobiosensors and nano-enabled deep-brain interface
devices (and more broadly in recent FTA work on NESTs), we have further articulated vital steps in a systematic forecasting
framework focused on identifying potential innovation pathways. Table 3 outlines candidate tools that could be selected for
application to each step of our integrated FTA process. These analysis steps and related tools could help anticipate future
innovation pathways and target effective emerging technology strategies.
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